论文部分内容阅读
Objective: Gastric cancer accounts for >325,000 deaths in China annually.The MET receptor and its ligand hepatocyte growth factor are promising targets in G/GEJ cancer.Our objective was to evaluate overall survival (OS) by tumor MET expression and by treatment disposition in Chinese patients with advanced G/GEJ cancer.